Reversal of propoxur-induced impairment of step-down passive avoidance, transfer latency and oxidative stress by piracetam and ascorbic acid in rats

Environmental Toxicology and Pharmacology

Volumn 28, Issue 3, 2009, Pages 403-408

  Gupta, Sparsh ^a   Garg, Gobind Rai ^a   Bharal, Nidhi ^a   Mediratta, P K ^a   Banerjee, B D ^a   Sharma, K K ^a  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

Author keywords

Ascorbic acid; Memory; Oxidative stress; Piracetam; Propoxur

Indexed keywords

ASCORBIC ACID; MALONALDEHYDE; PIRACETAM; PROPOXUR; THIOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; FUNCTIONAL ASSESSMENT; LATENT PERIOD; MALE; MAZE TEST; MENTAL FUNCTION; NONHUMAN; OXIDATIVE STRESS; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT; TREATMENT DURATION; TREATMENT RESPONSE;

RATTUS;

EID: 70349445402     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2009.06.007     Document Type: Article

References (53)

1. Aslan M., and Ozben T. Reactive oxygen and nitrogen species in Alzheimer's disease. Curr. Alzheimer Res. 1 (2004) 111-119
2. Babu G.R., Reddy G.R., Reddy A.T., Rajendra W., and Chetty C.S. Effect in vitro of propoxur on calcium dependent ATP hydrolysis and calcium uptake by the rat brain synaptosomes. Biochem. Int. 21 (1990) 1089-1094
3. Banerjee B.D., Seth V., Bhattacharya A., Pasha S.T., and Chakrabory A.K. Biochemical effects of some pesticides on lipid peroxidation and free radical scavengers. Toxicol. Lett. 107 (1999) 33-47
4. Bartus R., Dean III R.L., Sherman K.A., Friedman E., and Beer B. Profound effects of combining choline and piracetam on memory enhancement and cholinergic function in aged rats. Neurobiol. Aging 2 (1981) 105-111
5. Buresova O., and Bures J. Piracetam induced facilitation of interhemispheric transfer of visual information in rats. Psychopharmacologia 46 (1976) 93-102
6. Charlton K.E., Rabinowitz T.L., Geffen L.N., and Dhansay M.A. Lowered plasma vitamin C, but not vitamin E, concentration in dementia patients. J. Nutr. Health Aging 8 (2004) 99-107
7. Croisile B., Trillet M., Fondarai J., Laurent B., Mauguiere F., and Billardon M. Long-term and high-dose piracetam treatment of Alzheimer's disease. Neurology 43 (1993) 301-305
8. Delwing D., Bavaresco C.S., Monteiro S.C., Matte C., Netto C.A., and Wyse A.T. Alpha tocopherol and ascorbic acid prevent memory deficits provoked by chronic hyperprolinemia in rats. Behav. Brain Res. 168 (2006) 185-189
9. Dhingra D., Parle M., and Kulkarni S.K. Effect of combination of insulin with dextrose, d(-) fructose and diet on learning and memory in mice. Ind. J. Pharmacol. 35 (2003) 151-156
10. Dimond S.J., Scammell R.E., Pryce I.G., Huws D., and Gray C. Some effects of piracetam on chronic schizophrenia. Psychopharmacologia 64 (1979) 341-348
11. Dowla H.A., Panemanglore M., and Byers M.E. Comparative inhibition of enzymes of human erythrocytes and plasma in vitro by agricultural chemicals. Arch. Environ. Contam. Toxicol. 31 (1996) 107-114
12. Ellman G.L. Tissue sulphydryl groups. Arch. Biochem. Biophy. 82 (1959) 70-77
13. Fillenbaum G.G., Kuchibhatia M.N., Hanlon J.T., Artz M.B., Pieper C.F., Schmader K.E., et al. Dementia and Alzheimer's disease in community-dwelling elders taking vitamin C and/or vitamin E. Ann. Pharmacother. 39 (2005) 2009-2014
14. Giurgea C.E. The nootropic concept and its prospective implications. Drug Dev. Res. 2 (1982) 441-446
15. Hakkrainen H., and Hakamies L. Piracetam in the treatment of post-concussional syndrome. Eur. Neurol. 17 (1928) 50-55
16. Hallberg L. Iron and vitamins. Bibl. Nutr. Dieta. 52 (1995) 20-29
17. Hamilos D.L., and Wedner H.J. The role of glutathione in lymphocyte activation. I. Comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene-1-one by nuclear size transformation. J. Immunol. 135 (1985) 2740-2747
18. Harrison F.E., Sarah S., Kristen L., Brossche V.D., Li L., May J.M., et al. Elevated oxidative stress and sensorimotor deficits but normal cognition in mice that cannot synthesize ascorbic acid. J. Neurochem. 109 (2008) 1198-1208
19. Head E., Liu J., Hagen T.M., Muggenburg B.A., Milgram N.W., Ames A.B., et al. Oxidative damage increases with age in a canine model of human brain aging. J. Neurochem. 82 (2002) 375
20. Heise G.A., and Hudson J.D. Effects of pesticides and drugs on working memory in rats: continued delayed response. Pharmacol. Biochem. Behav. 23 (1985) 591-598
21. Hemila H., and Douglas R.M. Vitamin C and acute respiratory infections. Int. J. Tuberc. Lung Dis. 9 (1999) 756-761
22. Hunt C., Chakravorty N.K., Annan G., Habibzadeh N., and Schorah C.J. The clinical effects of vitamin C supplementation in elderly hospitalised patients with acute respiratory infections. Int. J. Vitam. Nutr. Res. 64 (1994) 212-219
23. Itoh J., Nabeshima T., and Kameyama T. Utility of an elevated plus-maze for the evaluation of memory in mice: effect of nootropics, scopolamine and electroconvulsive shock. Psychopharmacology 101 (1990) 27-33
24. Izquierdo I., Fin C., Schmitz P.K., Da Silva R.C., Jerusalinsky D., Quillfeldt J.A., et al. Memory enhancement by intrahippocampal, intraamygdala, orintraentorhinal infusion of platelet-activating factor measured in an inhibitory avoidance task. Proc. Natl. Acad. Sci. 92 (1995) 5047-5051
25. Joshi H., and Parle M. Brahmi rasayana improves learning and memory in mice. Evid. Based Complement. Altern. Med. 3 (2006) 79-85
26. Kamboj A., Kiran R., and Sandhir R. Carbofuran-induced neurochemical and neurobehavioral alterations in rats: attenuation by N-acetylcysteine. Exp. Brain Res. 170 (2006) 567-575
27. Keil U., Scherping I., Hauptmann S., Schuessel K., Eckert A., and Muller W.E. Piracetam improves mitochondrial dysfunction following oxidative stress. Br. J. Pharmacol. 147 (2006) 199-208
28. Landmark K. Could intake of vitamins C and E inhibit development of Alzheimer dementia?. Tidsskr Nor Laegeforen 126 (2006) 159-161
29. Lecanu L., Greeson J., and Papadopoulos V. Beta-amyloid and oxidative stress jointly induce neuronal death, amyloid deposits, gliosis, and memory impairment in the rat brain. Pharmacology 76 (2006) 19-33
30. Leung F.W., and Guze P.A. Adult scurvy. Ann. Emerg. Med. 10 (1981) 652-655
31. Mao X., and Yao G. Effect of vitamin C supplementations on iron deficiency anemia in Chinese children. Biomed. Environ. Sci. 5 (1992) 125-129
32. Mondadori C., Hengerer B., Ducret T., and Borkowoski J. Delayed emergence of effects of memory-enhancing drugs: implications for the dynamics of long-term memory. Proc. Natl. Acad. Sci. 91 (1994) 2041-2045
33. Muller W.E., Eckert G.P., and Eckert A. Piracetam: novelty in a unique mode of action. Pharmacopsychiatry 32 (1999) 2-9
34. Naidu P.S., Singh A., and Kulkarni K.S. Quercitin and reserpine induced orofacial dyskinesia. Pharmacology 70 (2004) 59-67
35. Nickolson V., and Wolthuis O. Effect of the acquisition-enhancing drug piracetam on rat cerebral energy metabolism. Biochem. Pharmacol. 25 (1976) 2241-2244
36. Okhawa H., Ohishi N., and Yagi K. Assay of lipid peroxides in animal tissue by thiobarbituric acid reaction. Anal. Biochem. 95 (1979) 351-358
37. Okuyama S., and Aihara H. Actions of nootropic drugs on transcallosal response of rats. Neuropharmacology 27 (1988) 67-72
38. Paleologos M., Cumming R.G., and Lazarus R. Cohort study of vitamin C intake and cognitive impairment. Am. J. Epidemiol. 148 (1998) 45-50
39. Parle M., and Dhingra D. Ascorbic acid: a promising memory-enhancer in mice. J. Pharmacol. Sci. 93 (2003) 129-135
40. Peterkovsky B. Ascorbate requirements for hydroxylation and secretion of procollagen: relation to inhibition of collagen synthesis in scurvy. Am. J. Clin. Nutr. 54 (1991) 35-40
41. Rowe D.J., Ko S., Tom X.M., Silverstein S.J., and Richards D.W. Enhanced production of mineralized nodules and collagenous proteins in vitro by calcium ascorbate supplemented with vitamin C metabolites. J. Periodontol. 70 (1999) 992-999
42. Ruiz M.J., Berrada H., and Fernandez M. Effects of carbamates as oxidative stressors on glutathione levels and lipid peroxidation in CHO-K1 cells. Toxicol. Lett. 164 (2006) S235-S236
43. Sato R., Helzisouer K.J., Comstock G.W., Hoffman S.C., Norkus E.P., and Fried L.P. A cross-sectional study of vitamin C and cognitive function in older adults: the differential effects of gender. J. Nutr. Health Aging 10 (2006) 37-44
44. Schmuck G., and Mihali F. Effects of the carbamates fenoxycarb, propamocarb and propoxur on energy supply, glucose utilization and SH-groups in neurons. Arch. Toxicol. 78 (2004) 330-337
45. Shahidi S., Komaki A., Mahmoodi M., Atrvash N., and Ghodrati M. Ascorbic acid supplementation could affect passive avoidance learning and memory in rats. Brain Res. Bull. 76 (2008) 109-113
46. Sharma D.C., and Mathur R. Correction of anemia and iron deficiency in vegetarians by administration of ascorbic acid. Ind. J. Physiol. Pharmacol. 39 (1995) 403-406
47. Smulders C.J., Bueters T.J., VanKleef R.G., and Vijverberg H.P. Selective effects of carbamate pesticides on rat neuronal nicotinic acetylcholine receptors and rat brain acetylcholinesterase. Toxicol. Appl. Pharmacol. 193 (2003) 139-146
48. Tacconi M., and Wurtman R. Piracetam: physiological disposition and mechanism of action. In: Fahn S., et al. (Eds). Advances in Neurology vol. 43 (1986), Raven Press, NY
49. Thiesen F.V., Barros H.M., Tannhauser M., and Tannhauser S.L. Behavioral changes and cholinesterase activity of rats acutely treated with propoxur. Jpn. J. Pharmacol. 79 (1999) 25-31
50. Vaananen M.K., Markkanen H.A., Tuovinen V.J., Kullaa A.M., Karinpaa A.M., Luoma H., et al. Dental caries and mutans streptococci in relation to plasma ascorbic acid. Scand. J. Dent. Res. 102 (1994) 103-108
51. Waegemans T., Wilsher C.R., Danniau A., Ferris S.H., Kurz A., and Winblad B. Clinical efficacy of piracetam in cognitive impairment: a meta-analysis. Dement. Geriatr. Cogn. Disord. 13 (2002) 217-224
52. Winblad B. Piracetam: a review of pharmacological properties and clinical uses. CNS Drug Rev. 11 (2005) 169-182
53. Yamauchi A., and Bloom E.T. Requirement of thiol compounds as reducing agents for IL-2-mediated induction of LAK activity and proliferation of human NK cells. J. Immunol. 151 (1993) 5535-5544